Evaluation of the EndoPAT as a Tool to Assess Endothelial Function

M Moerland, A J Kales, L Schrier, M G J van Dongen, D Bradnock, J Burggraaf, M Moerland, A J Kales, L Schrier, M G J van Dongen, D Bradnock, J Burggraaf

Abstract

Endothelial dysfunction is a potential target for (pharmaceutical) intervention of several systemic pathological conditions. We investigated the feasibility of the EndoPAT to evaluate acute changes in endothelial function with repeated noninvasive measurements and assessed its discriminating power in different populations. Endothelial function was stable over a longer period of time in renally impaired patients (coefficient of variation 13%). Endothelial function in renally impaired and type 2 diabetic patients was not decreased compared to healthy volunteers (2.9 ± 1.4 and 1.8 ± 0.3, resp., versus 1.8 ± 0.5, P > 0.05). The EndoPAT did not detect an effect of robust interventions on endothelial function in healthy volunteers (glucose load: change from baseline 0.08 ± 0.50, 95% confidence interval -0.44 to 0.60; smoking: change from baseline 0.49 ± 0.92, 95% confidence interval -0.47 to 1.46). This suggests that at present the EndoPAT might not be suitable to assess (changes in) endothelial function in early-phase clinical pharmacology studies. Endothelial function as measured by the EndoPAT could be physiologically different from endothelial function as measured by conventional techniques. This should be investigated carefully before the EndoPAT can be considered a useful tool in drug development or clinical practice.

Figures

Figure 1
Figure 1
Interventions and endothelial function. Reactive hyperemia index was assessed before and at 30 and 90 minutes after an oral glucose load (left) or after cigarette smoking (right).

References

    1. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104(22):2673–2678.
    1. Karatzi K, Papamichael C, Karatzis E, et al. Acute smoking induces endothelial dysfunction in healthy smokers. Is this reversible by red wine’s antioxidant constituents? Journal of the American College of Nutrition. 2007;26(1):10–15.
    1. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long- term outcome of coronary heart disease. Circulation. 2000;101(16):1899–1906.
    1. Stern MP. Diabetes and cardiovascular disease: the ’common soil’ hypothesis. Diabetes. 1995;44(4):369–374.
    1. Bolad I, Delafontaine P. Endothelial dysfunction: its role in hypertensive coronary disease. Current Opinion in Cardiology. 2005;20(4):270–274.
    1. Vanhoutte PM. Endothelial dysfunction—the first step toward coronary arteriosclerosis. Circulation Journal. 2009;73(4):595–601.
    1. Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diabetes and Vascular Disease Research. 2007;4(2):84–88.
    1. Meyers MR, Gokce N. Endothelial dysfunction in obesity: etiological role in atherosclerosis. Current Opinion in Endocrinology, Diabetes and Obesity. 2007;14(5):365–369.
    1. Kawano H, Motoyama T, Hirai N, Kugiyama K, Yasue H, Ogawa H. Endothelial dysfunction in hypercholesterolemia is improved by L-arginine administration: possible role of oxidative stress. Atherosclerosis. 2002;161(2):375–380.
    1. Betik AC, Luckham VB, Hughson RL. Flow-mediated dilation in human brachial artery after different circulatory occlusion conditions. American Journal of Physiology. 2004;286(1):H442–H448.
    1. Vogel RA, Corretti MC, Plotnick GD. A comparison of brachial artery flow-mediated vasodilation using upper and lower arm arterial occlusion in subjects with and without coronary risk factors. Clinical Cardiology. 2000;23(8):571–575.
    1. Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. American Heart Journal. 2003;146(1):168–174.
    1. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham heart study. Circulation. 2008;117(19):2467–2474.
    1. Kuvin JT, Mammen A, Mooney P, Alsheikh-Ali AA, Karas RH. Assessment of peripheral vascular endothelial function in the ambulatory setting. Vascular Medicine. 2007;12(1):13–16.
    1. Haller MJ, Stein J, Shuster J, et al. Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes. Pediatric Diabetes. 2007;8(4):193–198.
    1. Mahmud FH, Earing MG, Lee RA, Lteif AN, Driscoll DJ, Lerman A. Altered endothelial function in asymptomatic male adolescents with type 1 diabetes. Congenital Heart Disease. 2006;1(3):98–103.
    1. Mahmud FH, Van Uum S, Kanji N, Thiessen-Philbrook H, Clarson CL. Impaired endothelial function in adolescents with type 1 diabetes mellitus. Journal of Pediatrics. 2008;152(4):557–562.
    1. Shachor-Meyouhas Y, Pillar G, Shehadeh N. Uncontrolled type 1 diabetes mellitus and endothelial dysfunction in adolescents. Israel Medical Association Journal. 2007;9(9):637–640.
    1. Barringer TA, Hatcher L, Sasser HC. Potential benefits on impairment of endothelial function after a high-fat meal of 4 weeks of flavonoid supplementation. Evidence-Based Complementary and Alternative Medicine. 2011;2011:6 pages. Article ID 796958.
    1. Fisher NDL, Hughes M, Gerhard-Herman M, Hollenberg NK. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. Journal of Hypertension. 2003;21(12):2281–2286.
    1. Fisher NDL, Hollenberg NK. Aging and vascular responses to flavanol-rich cocoa. Journal of Hypertension. 2006;24(8):1575–1580.
    1. Schroeter H, Heiss C, Balzer J, et al. (−)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(4):1024–1029.
    1. Aversa A, Vitale C, Volterrani M, et al. Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes. Diabetic Medicine. 2008;25(1):37–44.
    1. Yeo TW, Lampah DA, Gitawati R, et al. Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. Journal of Infectious Diseases. 2008;198(4):602–608.
    1. Linden E, Cai W, He JC, et al. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clinical Journal of the American Society of Nephrology. 2008;3(3):691–698.
    1. Rossi M, Cupisti A, Di Maria C, Galetta F, Barsotti G, Santoro G. Blunted post-ischemic increase of the endothelial skin blood flowmotion component as early sign of endothelial dysfunction in chronic kidney disease patients. Microvascular Research. 2008;75(3):315–322.
    1. Verbeke FH, Agharazii M, Boutouyrie P, Pannier B, Guérin AP, London GM. Local shear stress and brachial artery functions in end-stage renal disease. Journal of the American Society of Nephrology. 2007;18(2):621–628.
    1. Kruger A, Stewart J, Sahityani R, et al. Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk. Kidney International. 2006;70(1):157–164.
    1. Feng B, Chen Y, Luo Y, Chen M, Li X, Ni Y. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis. 2010;208(1):264–269.
    1. Karabag T, Kaya A, Temizhan A, Koç F, Yavuz S, Çam S. The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease. Acta Diabetologica. 2007;44(2):69–75.
    1. Reyes-Soffer G, Holleran S, Di Tullio MR, et al. Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus. Metabolism. 2010;59(9):1365–1371.
    1. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. Journal of the American College of Cardiology. 2004;43(10):1731–1737.
    1. Title LM, Cummings PM, Giddens K, Nassar BA. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. Journal of the American College of Cardiology. 2000;36(7):2185–2191.
    1. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 1998;97(17):1695–1701.
    1. Nichols WW, Singh BM. Augmentation index as a measure of peripheral vascular disease state. Current Opinion in Cardiology. 2002;17(5):543–551.
    1. Wang X, Keith JC, Struthers AD, Feuerstein GZ. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. Cardiovascular Therapeutics. 2008;26(3):214–223.
    1. Weber T, Auer J, O’Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109(2):184–189.
    1. Vyssoulis GP, Pietri PG, Karpanou EA, et al. Differential impact of metabolic syndrome on arterial stiffness and wave reflections: focus on distinct definitions. International Journal of Cardiology. 2010;138(2):119–125.
    1. Deloach SS, Appel LJ, Chen J, et al. Aortic pulse pressure is associated with carotid IMT in chronic kidney disease: report from chronic renal insufficiency cohort. American Journal of Hypertension. 2009;22(12):1235–1241.
    1. Lind L, Granstam SO, Millgård J. Endothelium-dependent vasodilation in hypertension: a review. Blood Pressure. 2000;9(1):4–15.
    1. Levin A, Djurdjev O, Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. American Journal of Kidney Diseases. 2001;38(6):1398–1407.
    1. Gordon SE, Cartwright N, Griffiths MJD. Investigation of endothelial function by pulse contour analysis: a protocol for drug administration and timing of pulse contour assessment. British Journal of Clinical Pharmacology. 2009;68(4):630–633.
    1. Abbink EJ, Pickkers P, Jansen Van Rosendaal A, et al. Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients. Diabetic Medicine. 2002;19(2):136–143.
    1. Papathanassiou K, Naka KK, Kazakos N, et al. Pioglitazone vs glimepiride: differential effects on vascular endothelial function in patients with type 2 diabetes. Atherosclerosis. 2009;205(1):221–226.
    1. Spallarossa P, Schiavo M, Rossettin P, et al. Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia. Diabetes Care. 2001;24(4):738–742.
    1. Siasos G, Tousoulis D, Vlachopoulos C, et al. The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance. American Journal of Hypertension. 2009;22(6):586–592.
    1. Esen AM, Barutcu I, Acar M, et al. Effect of smoking on endothelial function and wall thickness of brachial artery. Circulation Journal. 2004;68(12):1123–1126.
    1. Zhu W, Zhong C, Yu Y, Li K. Acute effects of hyperglycaemia with and without exercise on endothelial function in healthy young men. European Journal of Applied Physiology. 2007;99(6):585–591.
    1. Black MA, Cable NT, Thijssen DHJ, Green DJ. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension. 2008;51(2):203–210.
    1. Montagnana M, Salvagno GL, Lippi G. Circadian variation within hemostasis: an underrecognized link between biology and disease? Seminars in Thrombosis and Hemostasis. 2009;35(1):23–33.
    1. Kawano H, Motoyama T, Yasue H, et al. Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina. Journal of the American College of Cardiology. 2002;40(2):266–270.
    1. Shaw JA, Chin-Dusting JPF, Kingwell BA, Dart AM. Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation. 2001;103(6):806–812.
    1. Otto ME, Svatikova A, De Mattos Barretto RB, et al. Early morning attenuation of endothelial function in healthy humans. Circulation. 2004;109(21):2507–2510.
    1. Järvisalo MJ, Jartti L, Marniemi J, et al. Determinants of short-term variation in arterial flow-mediated dilatation in healthy young men. Clinical Science. 2006;110(4):475–482.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit